EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    3.5.4.5 | Acidosis |
2396864 |
Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
1
1
0 |
| 3.5.4.5 | Acquired Immunodeficiency Syndrome |
12713818 |
A novel cytidine deaminase AIDs in the delivery of error-prone polymerases to immunoglobulin genes. |
causal interaction
unassigned |
1
0 |
| 3.5.4.5 | Adenocarcinoma |
19531250 |
Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
| 3.5.4.5 | Adenocarcinoma |
21737888 |
Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
4
2
0 |
| 3.5.4.5 | Adenocarcinoma |
21890457 |
Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 3.5.4.5 | Adenocarcinoma |
23995783 |
Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase. |
causal interaction
therapeutic application
unassigned |
3
2
0 |
| 3.5.4.5 | Adenocarcinoma |
24498570 |
Macrophages increase the resistance of pancreatic adenocarcinoma cells to gemcitabine by upregulating cytidine deaminase. |
causal interaction
unassigned |
2
0 |
| 3.5.4.5 | Adenocarcinoma |
24511045 |
The role of activation-induced cytidine deaminase expression in gastric adenocarcinoma. |
causal interaction
unassigned |
4
0 |
| 3.5.4.5 | Adenocarcinoma |
31624127 |
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
3
2
4 |
| 3.5.4.5 | Adenocarcinoma of Lung |
2932216 |
Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
1
2
0 |
